Canada markets open in 2 hours 31 minutes

Ascentage Pharma Group International (36X.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.1800+0.0400 (+1.87%)
As of 09:59AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
221,984
221,984
209,711
27,910
12,450
Cost of Revenue
30,543
30,543
21,998
3,328
1,966
Gross Profit
191,441
191,441
187,713
24,582
10,484
Operating Expenses
Research Development
706,972
706,972
743,104
766,491
564,571
Selling General and Administrative
376,463
376,463
328,016
191,261
64,058
Total Operating Expenses
1,064,077
1,064,077
1,037,523
894,417
674,425
Operating Income or Loss
-872,636
-872,636
-849,810
-869,835
-663,941
Interest Expense
96,057
96,057
52,785
16,731
6,255
Income Before Tax
-932,862
-932,862
-887,172
-832,249
-675,448
Income Tax Expense
-7,150
-7,150
-4,248
-49,825
2,158
Income from Continuing Operations
-925,712
-925,712
-882,924
-782,424
-677,606
Net Income
-925,637
-925,637
-882,924
-782,424
-677,606
Net Income available to common shareholders
-925,637
-925,637
-882,924
-782,424
-677,606
Basic EPS
-3.28
-3.28
-3.35
-3.07
-3.14
Diluted EPS
-3.28
-3.28
-3.35
-3.07
-3.14
Basic Average Shares
269,109
282,299
263,669
254,615
215,909
Diluted Average Shares
269,109
282,299
263,669
254,615
215,909